Staying on a lower dose of Wegovy: when it makes sense and what to expect

You're on 1mg and things feel right, now what?

Picture this: you've been on Wegovy for a few months, you're at 1mg, your appetite has settled, you're losing weight steadily, and the nausea that plagued the first few weeks has mostly cleared. Your prescription says the next step is 1.7mg. But you're not sure you want to go there. This is one of the most common questions our prescribers hear.

The titration ladder (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, taken roughly four weeks apart) exists primarily to help your body adjust to semaglutide gradually. It isn't a race, and reaching 2.4mg is not the point of treatment on its own. The point is meaningful, sustained weight loss alongside improved health. If you want to understand what staying at a reduced level involves, our Wegovy lower dose page explains the clinical reasoning in detail.

A quick habit worth building: weigh yourself on the same morning each week, before breakfast, and note it somewhere, a phone note is fine. That pattern gives your prescriber something concrete to work from when you discuss whether your current dose is pulling its weight, so to speak.

The NHS medicines page for semaglutide confirms that dosing is titrated based on tolerability, and the final maintenance dose is a clinical decision, not a fixed destination for every patient.

What staying on a lower dose actually means for your results

There is a real trade-off to understand. Trial data from the STEP programme showed that higher doses of semaglutide generally produce greater average weight reduction. At 2.4mg over 68 weeks, participants in STEP 1 lost around 15% of their body weight on average. At lower doses, the effect is typically smaller, though individual responses vary considerably, and some people do achieve significant progress at 1mg or 1.7mg.

If you're curious how outcomes compare between Wegovy and tirzepatide at various doses, the Wegovy overview page covers the evidence clearly. For more detail on how the doses compare within the Wegovy schedule itself, the Wegovy doses page is worth reading alongside this one.

Current NICE guidance for semaglutide (TA875) includes a practical checkpoint: if less than 5% weight loss has occurred after six months at the maintenance dose, continuing the medicine should be reconsidered. This means your prescriber will be looking at your trajectory over time, not just whether you feel comfortable right now. Staying lower indefinitely is not automatically ruled out, but it does require that your progress justifies it. That's a conversation, not a checkbox.

It's also worth noting that some people step back down from a higher dose if side effects become unmanageable, then find a lower dose is actually their sweet spot. Stepping down is not failure, it's personalised medicine.

When a lower dose might genuinely be the right long-term answer

There are specific circumstances where a prescriber might actively support staying on a lower dose rather than pushing upward. If gastrointestinal side effects at 1.7mg or 2.4mg are severe enough to affect daily life (persistent nausea, frequent vomiting, significant diarrhoea) the clinical calculus shifts. A dose you can sustain beats one you abandon after two weeks.

People with certain other health conditions or those taking medicines that interact with semaglutide may also find their prescriber recommends a more conservative approach. This is exactly why a clinician reviews every repeat prescription: the right dose for you at month three may not be the same answer at month nine.

If you've been transferred from another provider and you're settled on 1mg, our prescribers at nume will ask to see evidence of your current treatment before any changes are made, standard clinical practice, and a safeguard worth having. You can read more about how the process works on the about us page.

For more on the clinical reasoning behind holding at a specific point, this page on staying on a lower dose of Wegovy explores the topic from a slightly different angle. There's also a dedicated look at staying on 1mg specifically if that's the dose in question for you.

How to have this conversation with your prescriber

Prescribers don't expect you to simply follow a chart. They expect you to tell them how you're doing. If you want to stay on your current dose, the most useful things to bring to that conversation are: your weight trend over the past four to eight weeks, a clear description of any side effects you've experienced at the current or previous dose, and your honest assessment of how the treatment is affecting your daily life.

What you don't need to do is self-manage. Adjusting your dose without clinical sign-off (in either direction) creates gaps in your clinical record and removes the safety checks that exist for good reason. If you're weighing the cost of continuing treatment against changing doses, the Wegovy pricing page gives straightforward context on what's included when you go through a properly regulated service.

Semaglutide is a prescription-only medicine, and the right maintenance dose is a clinical judgement, not a default setting. Speak to our prescribers, they review every case individually, read your notes personally, and can advise on whether holding where you are is the right call for you. To get started, visit the treatments page and begin your free consultation.